AMPE - Speculative LongAMPIO has been in the news for treatment of COVID, and most recently for 2 trials treating 2 different types of inflammatory diseases, one is kidney related and would be very important in future treatments of Kidney Disease with chronic inflammation. I believe this would be the best case scenario, if found to be effective. Current price, $1.20 - Technically I would not recommend an entry here, too much downside risk.
Best entries would be between the range of $.75 - $.88, especially important if price bounces from either level. If price hits a fib entry zone, and bounces, wait for closing candle to confirm. This would be best possible entry with minimal downside, as price has been in pattern similar to this over last couple months.
AMPE
AMP Trade OpportunityAMP Technical looking good, we have set trend reversal alert for 3k satoshi which is support turned resistance, which will serve as our entry point.
We have a little opportunity in a channel trade here, movement to top of channel is around 700% gains.
Market cap is $20M and is in social media sector with less than 5 competitors, 2 biggest being IFT (investment niche) and steemit.
This one focuses more on preserving good content on web with incentive to do so.
The product is Wildspark and has some upcoming news:
The February 13th Update – WildSpark Goes Mainstream
The major update, due to be released on February 13, 2018, will shift WildSpark from an extension into a full web-app. It will provide an extensive enhancement to WildSpark’s core capabilities, with a multitude of new and powerful features:
Threaded commenting system for each piece of content, with in-browser notifications facilitating an ongoing discussion.
Support for content from various platforms in addition to YouTube, including text, music, images, and GIFs.
Amplifying content, with the recipients getting AMPs, using any type of currency – crypto and fiat.
Creating personal profiles, building a unique WildSpark identity.
Earning rewards for referring people to sign up and use WildSpark.
Back to the technical analysis,
MACD blue line looking to cross orange from downside to upside, stoch RSI supports upward movement, possible 3 dives pattern (not entirely sure if valid so take with caution).
Risk reward looks very favorable in this pair.
We are not entering yet but this is definitely a project we will add to core holdings for 2018 and beyond with product release in Q1.
Linked a related idea to a much better overall analysis done by Papou that only has 442 and is certainly overlooked.
AMPE - Fallen angel formation Long from $1.35 to $1.63AMPE seems forming a nice base in long time-frame. And in short term it seems breakout out of a Flag formation. We think it has good upside potential from current price.
* Trade Criteria *
Date First Found- November 17, 2017
Pattern/Why- Flag formation, Fallen angel (Long term)
Entry Target Criteria- at current price
Exit Target Criteria- $1.63
Stop Loss Criteria- $1.23
Please check back for Trade updates. (Note: Trade update is little delayed here.)
UPDATE: AMPION REGENRATION OF CARTILEDGE UNTAPPED MARKETAS PREVIOUSLY STATED THIS IS ANOTHER BIOTECH THAT WILL CHANGE THE OSTEOARTHRITIS MARKET HOWEVER UNTIL ABOUT AN HOUR AGO THIS WAS SOMETHING THAT COULD NOT BE FOUND AS SIMPLY AS THIS LINK us.rd.yahoo.com . ALL INVESTORS SHOULD POSITION INTO THIS IT HAS A TENDENCY TO TRADE TO 10 FROM 7 BUT IN THIS CASE THE PRICE TARGETS RANGE FROM 15-18-21 21 BEING THE BIGGEST BANK CITIGROUP'S BUY TARGET.
STOP SHOULD BE 7.2105 AND IT SHOULD BE A TRAILING STOP LOSS . MOVING WITH STOCK PRICE DAILY
DONT BE TOO LATE FOR A MULTIPLE TRILLION DOLLAR DRUG MARKET THAT THE WORLD HAS YET TO DISCOVER A DRUG FOR UNTIL NOW AMPION!!!!!!!
